Nintena 150mg Softgel Caps (Nintedanib)
Medicine OverView
Nintena 150mg Softgel Caps (Nintedanib) is a prescription medicine used in the treatment of Idiopathic Pulmonary Fibrosis (IPF), chronic fibrosing interstitial lung diseases (ILDs), and progressive pulmonary fibrosis. It contains Nintedanib 150mg, an antifibrotic medicine that helps slow the progression of fibrosis and lung tissue scarring.
Nintedanib works by blocking multiple pathways responsible for fibrosis and abnormal tissue growth inside the lungs. It helps reduce the decline in lung function and supports long-term respiratory disease management in eligible patients.
Nintena 150mg Softgel Caps is commonly prescribed under specialist supervision for progressive fibrosing lung conditions requiring antifibrotic therapy.
This medicine should only be used under the supervision of qualified healthcare professionals experienced in pulmonary disease treatment.
Nintena 150mg Softgel Caps is used for the treatment and management of fibrosing lung diseases.
Doctors prescribe Nintena 150mg Softgel Caps depending on disease severity, progression rate, lung function, and patient response to treatment.
Nintena 150mg Softgel Caps contains Nintedanib, an antifibrotic medicine.
Nintedanib works by:
By targeting multiple fibrosis pathways, Nintena 150mg Softgel Caps helps slow lung damage progression and supports long-term respiratory care.
Nintena 150mg Softgel Caps offers several important benefits in pulmonary fibrosis treatment.
Proper pulmonary treatment and regular specialist monitoring are important for improving long-term respiratory outcomes.
Pulmonary fibrosis and interstitial lung diseases are chronic lung disorders characterized by scarring and thickening of lung tissue.
Common symptoms may include:
Early diagnosis and specialist pulmonary care help support better disease control and long-term respiratory health.
The dosage of Nintena 150mg Softgel Caps depends on:
Important usage instructions:
Regular liver function tests and respiratory evaluations may be required during treatment.
Like all medicines, Nintena 150mg Softgel Caps may cause side effects in some patients.
Seek immediate medical attention if you experience:
Regular medical monitoring helps support safe long-term antifibrotic treatment.
Before using Nintena 150mg Softgel Caps, inform your doctor if you have:
Important Warning: Nintedanib may increase the risk of liver-related complications and bleeding in some patients.
Do not stop treatment without medical advice.
Nintena 150mg Softgel Caps may interact with several medicines.
Always inform your healthcare provider about all medicines, supplements, and herbal products you are using.
Pregnancy: Nintena 150mg Softgel Caps should only be used during pregnancy if specifically advised by your healthcare provider.
Breastfeeding: Consult your doctor before using Nintedanib while breastfeeding.
Always discuss treatment risks and benefits before starting therapy.
Nintena 150mg Softgel Caps is used for pulmonary fibrosis, interstitial lung disease, and progressive fibrosing lung disorders.
It contains Nintedanib 150mg.
It works by blocking fibrosis pathways and slowing abnormal lung tissue scarring.
No, it does not cure pulmonary fibrosis, but it helps slow disease progression and supports lung function management.
Regular monitoring helps evaluate liver function, respiratory health, and overall treatment safety.
Yes, Nintena 150mg Softgel Caps should only be used under specialist medical supervision.
You can buy Nintena 150mg Softgel Caps (Nintedanib) online from a licensed pharmacy with a valid prescription. Always purchase pulmonary medicines from trusted suppliers to ensure product authenticity, quality, and proper storage conditions.
Before purchasing online:
What do you think about this product?